AUGA:LSE:LSE-UBS (Irl) ETF plc - MSCI Australia UCITS ETF (hedged to GBP) A-acc (GBX)

ETF | Others |

Last Closing

USD 2397

Change

-19.25 (-0.80)%

Market Cap

N/A

Volume

497.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-0.13 (-0.05%)

USD 292,109.69B
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

-20.50 (-0.11%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+2.75 (+1.42%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.22 (-1.20%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.22 (-1.55%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

+1.37 (+1.27%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-0.37 (-1.21%)

USD 260.39B
0QZO:LSE 0QZO

-4.20 (-4.09%)

USD 258.54B

ETFs Containing AUGA:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.76% 29% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.76% 29% F 36% F
Trailing 12 Months  
Capital Gain 4.25% 50% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.25% 45% F 52% F
Trailing 5 Years  
Capital Gain 38.34% 43% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.34% 39% F 52% F
Average Annual (5 Year Horizon)  
Capital Gain 13.00% 71% C- 73% C
Dividend Return 13.00% 70% C- 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.14% 67% D+ 82% B
Risk Adjusted Return 128.20% 98% N/A 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike